Effect of medications misused for body weight gain on sodium and potassium concentration of female rabbits
DOI:
https://doi.org/10.30574/gscbps.2018.2.1.0054Keywords:
Administered drugs, Female rabbits, Sodium and potassium concentration, Body weightAbstract
The objective of this study was to determine the effect of some drugs on body weight, potassium and sodium concentration of female rabbits. A randomized complete block design with three replicates was used, the treatments consisted of 3 drugs of dexamethasone, cyperoheptadine and the combination of dexamethasone and cyperoheptadine administered orally with doses of 0.9 mg/kg of body weight with drugs two times a day for 45 days. Body weight and the concentration of sodium and potassium were measured. The results showed that body weight and the concentration of sodium and potassium significantly affected with treatments. The cyperoheptadine of this drugs increased body weight from (910 at zero time to 1693 g at the end of experimental period), where the increments found to be out of the normal range (16 g). It was found that potassium concentration decreased with time and the final values were (2.20 mg/dl), (2.60 mg/dl), (3.20 mg/dl) for dexamethasone, the combination and cyperoheptadine, respectively. No significant differences between these values found and they were below the normal range of potassium concentration (4.0–6.5 mg/dl). According to the results found the study concluded that cyperoheptadine and the combination increased body weight. All drugs decreased potassium concentration. Physician and pharmacist should be consultant before using these drugs to avoid the adverse effects is needed as recommended point of view, effects of drugs on serum total cholesterol, triglyceride, high-density lipoprotein, low density lipoprotein and very low density lipoprotein are also recommended for future work.
Metrics
References
Pagana KD and Pagana TJ. (2010). Mosby’s manual of diagnostic and laboratory tests, 4th ed. St. Louis: Mosby Elsevier.
De Wasch K, De Brabander HF, Van De Wiele M, VarcammenJ and Courtheyn D. (2001). Differentiation between dexamethasone and betamethasone in a mature using multiple mass spectrometry. Journal of Chromatography A, 926, 79 – 86.
Siddigui E and Qazi GI. (2012).Role of dexamethasone in meningitis. In: Meningitis, Wireko-Brobby G. (Ed.) Intech, USA.
Bloom SL, Sheffield JS, McIntire DD and Leveno KJ. (2001). Antenatal dexamethasone and decreased birth weight. Obstetrics and Gynecology, 97, 485-490.
Welsh AL and Ede M. (2013). Studies of cyperoheptadine combined with dexamethasone. Journal of Clinical Pharmacology, 2, 223 – 231.
Murray RK, Granner DK, Mayes PA and Rodwell VW. (2006). Harper lustrated Biochemistry. 27th ed., MC Graw-Hill, New York, 489-504.
Sendecor GW and Cochran WC. (1989). Statistical Method, 8th Ed. Iowa State University press, Ames, Iowa.
Rashad FG and Ala AL-deen HJ. (2013). Effects of dexamethasone, estrogen administration on leptin, thyroid, reproductive hormone concentration and lipid profile of female rabbits serum. Basrah Journal of Veterinary Research. 12(1), 41–53.
Amar MI, Shama IA, Enaia AA, Hind AEO and Hager AM. (2013). Effects of various levels of oral doses dexamethasone (Al-nagma) abused as cosmetic by Sudanese women on Wistar rats. Journal of Medical Sciences, 13(6), 432.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.